Derek DiRocco

Insider Reports History

Entity
Individual
Location
535 Mission Street, 14 Th Floor, San Francisco, CA
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Derek DiRocco:

Stock Role Class Num Shares Value Price $ Report Date Ownership
89bio, Inc. Director Stock Option (Right to Buy) 45.2K Feb 1, 2024 Direct
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 22.4K Jun 13, 2023 Direct
Mineralys Therapeutics, Inc. Director Stock Option 22K May 22, 2024 Direct
Acrivon Therapeutics, Inc. Director Stock Option (Right to Buy) 20.3K Jun 20, 2024 Direct
Werewolf Therapeutics, Inc. Director Stock Option (right to buy) 17.5K May 24, 2024 Direct

Insider Reports Filed by Derek DiRocco

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRV Acrivon Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
HOWL Werewolf Therapeutics, Inc. May 24, 2024 1 $0 4 May 24, 2024 Director
MLYS Mineralys Therapeutics, Inc. May 22, 2024 1 $0 4 May 23, 2024 Director
ETNB 89bio, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 Director
HOWL Werewolf Therapeutics, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
ITOS iTeos Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director
ETNB 89bio, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 0 $0 3 Feb 9, 2023 Director
ACRV Acrivon Therapeutics, Inc. Nov 14, 2022 1 $0 4 Nov 16, 2022 Director
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 Director
ITOS iTeos Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
HOWL Werewolf Therapeutics, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
ETNB 89bio, Inc. May 16, 2022 1 $0 4 May 18, 2022 Director
ITOS iTeos Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director